Cellosaurus 201T (CVCL_X481)

Cell line name 201T
Accession CVCL_X481
Resource Identification Initiative To cite this cell line use: 201T (RRID:CVCL_X481)
Comments Microsatellite instability: Instable (MSI-low) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Disease Lung adenocarcinoma (NCIt: C3512)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): Cosmic-CLP

Markers:
AmelogeninX,Y
CSF1PO7,13
D13S31711,13
D16S53911,12
D5S81812,13
D7S8209,10
TH017
TPOX6,8
vWA15
Publications

PubMed=9816093
Kasprzyk P.G., Sullivan T.L., Hunt J.D., Gubish C.T., Scoppa C.A., Oelkuct M., Bird R., Fischer P.H., Siegfried J.M., King C.R.
Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification.
Clin. Cancer Res. 2:75-80(1996)

PubMed=15735034; DOI=10.1158/0008-5472.CAN-04-1872
Stabile L.P., Lyker J.S., Gubish C.T., Zhang W., Grandis J.R., Siegfried J.M.
Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
Cancer Res. 65:1459-1470(2005)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line databases/resources Cosmic-CLP; 1287381
GDSC; 1287381
Gene expression databases GEO; GSM827492
GEO; GSM1669564
Polymorphism and mutation databases Cosmic; 910550